DIN 02523191 — IXIFI 100 MG
IXIFI is a powder for solution of Infliximab marketed by PFIZER CANADA ULC. The full Infliximab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02523191
- Brand name
- IXIFI
- Active ingredient
- Infliximab
- Strength
- 100 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- PFIZER CANADA ULC
- Health Canada status
- MARKETED
- Drug class
- Tumour necrosis factor (TNF)-alpha inhibitor (biologic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Infliximab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02496933 | AVSOLA | 100 MG | POWDER FOR SOLUTION | AMGEN CANADA INC | MARKETED |
| 02419475 | REMDANTRY | 100 MG | POWDER FOR SOLUTION | CELLTRION INC. | MARKETED |
| 02244016 | REMICADE | 100 MG | POWDER FOR SOLUTION | JANSSEN INC | MARKETED |
| 02511584 | REMSIMA SC | 120 MG | KIT; SOLUTION | CELLTRION INC. | MARKETED |
| 02470373 | RENFLEXIS | 100 MG | POWDER FOR SOLUTION | SAMSUNG BIOEPIS CO., LTD | MARKETED |